Vinay Kumar Nilagiri

Vinay Kumar Nilagiri

Auto-generated profile, based on publicly available information

Vinay Kumar Nilagiri

Centre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute) University of Western Australia Perth Western Australia Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2022 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Open access
SLSamantha S. Y. Lee
Samantha S. Y. Lee
VNVinay K. Nilagiri
Vinay K. Nilagiri
DMDavid A. Mackey
David A. Mackey
There is a growing body of literature on the effects of sleep disorders, in particular obstructive sleep apnoea (OSA), on ocular health, with consistent evidence of an increased risk of floppy eyelid syndrome, non‐arteritic anterior ischaemic optic neuropathy, diabetic macular oedema, and other retinal vasculature changes in individuals with OSA. However, reports on OSA's associations with glaucoma, papilloedema, diabetic retinopathy, central serous chorioretinopathy, and keratoconus have been conflicting, while links between OSA and age‐related macular degeneration have only been described fairly recently. Despite numerous suggestions that OSA treatment may reduce risk of these eye diseases, well‐designed studies to support these claims are lacking. In particular, the ocular hypertensive effects of continuous positive airway pressure (CPAP) therapy for OSA requires further investigation into its potential impact on glaucoma risk and management. Reports of ocular surface complications secondary to leaking CPAP masks highlights the importance of ensuring good mask fit. Poor sleep habits have also been linked with increased myopia risk; however, the evidence on this association remains weak.

23 February 2024 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Open access
SLSamantha Sze‐Yee Lee
Samantha Sze‐Yee Lee
VNVinay Kumar Nilagiri
Vinay Kumar Nilagiri
GLGareth Lingham
Gareth Lingham
MBMagdalena Blaszkowska
Magdalena Blaszkowska
PSPaul G. Sanfilippo
Paul G. Sanfilippo
DMDavid A. Mackey
David A. Mackey
Background: A rebound in myopia progression following cessation of atropine eyedrops has been reported, yet there is limited data on the effects of stopping 0.01% atropine compared to placebo control. This study tested the hypothesis that there is minimal rebound myopia progression after cessation of 0.01% atropine eyedrops, compared to a placebo.Methods: Children with myopia (n = 153) were randomised to receive 0.01% atropine eyedrops or a placebo (2:1 ratio) daily at bedtime during the 2‐year treatment phase of the study. In the third year (wash‐out phase), all participants ceased eyedrop instillation. Participants underwent an eye examination every 6 months, including measurements of spherical equivalent (SphE) after cycloplegia and axial length (AL). Changes in the SphE and AL during the wash‐out phase and throughout the 3 years of the study (treatment + wash‐out phase) were compared between the treatment and control groups.Results: During the 1‐year wash‐out phase, SphE and AL progressed by −0.41D (95% CI = −0.33 to −0.22) and +0.20 mm (95% CI = −0.46 to −0.36) in the treatment group compared to −0.28D (95% CI = 0.11 to 0.16) and +0.13 mm (95% CI = 0.18 to 0.21) in the control group. Progression in the treatment group was significantly faster than in the control group (p = 0.016 for SphE and <0.001 for AL). Over the 3‐year study period, the cumulative myopia progression was similar between the atropine and the control groups.Conclusions: These findings showed evidence of rapid myopia progression following cessation of 0.01% atropine. Further investigations are warranted to ascertain the long‐term effects of atropine eyedrops.

13 August 2021 in Ophthalmic and Physiological Optics
Verified
Journal Article
Closed access
PDF file
VNVinay Kumar Nilagiri
Vinay Kumar Nilagiri
MSMarwan Suheimat
Marwan Suheimat
ALAndrew Lambert
Andrew Lambert
DADavid A Atchison
David A Atchison